CINF
50
-3
TDC
73
2
BXP
52
2
PCG
94
-5
CSX
62
-6
IRM
39
-3
ACN
52
-18
IR
68
-3
MOS
42
3
CME
58
-4
ETN
79
-5
PM
64
6
EL
20
2
GOOGL
54
-5
HPE
48
-22
AAL
59
2
ES
29
3
SE
57
-3
HUM
46
-2
ORLY
66
-3
CINF
50
-3
TDC
73
2
BXP
52
2
PCG
94
-5
CSX
62
-6
IRM
39
-3
ACN
52
-18
IR
68
-3
MOS
42
3
CME
58
-4
ETN
79
-5
PM
64
6
EL
20
2
GOOGL
54
-5
HPE
48
-22
AAL
59
2
ES
29
3
SE
57
-3
HUM
46
-2
ORLY
66
-3
Financhill
Back

Krystal Biotech Vs. Alnylam Pharmaceuticals Industry Stock Comparison

Sell
43

KRYS
Krystal Biotech

Last Price:
177.41
Seasonality Move:
21.68%
Sell
28

ALNY
Alnylam Pharmaceuticals

Last Price:
258.10
Seasonality Move:
10.85%
Sell
43
Krystal Biotech (KRYS) is a Sell

Is Krystal Biotech a Buy, Sell or Hold?

  • The current Krystal Biotech [KRYS] share price is $177.39. The Score for KRYS is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • KRYS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
28
Alnylam Pharmaceuticals (ALNY) is a Sell

Is Alnylam Pharmaceuticals a Buy, Sell or Hold?

  • The current Alnylam Pharmaceuticals [ALNY] share price is $257.91. The Score for ALNY is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
  • ALNY is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

KRYS Stock Price Chart

What is Krystal Biotech's stock price today?

  • The Krystal Biotech share price today is $177.39
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KRYS is experiencing selling pressure, which indicates risk of future bearish movement.

ALNY Stock Price Chart

What is Alnylam Pharmaceuticals's stock price today?

  • The Alnylam Pharmaceuticals share price today is $257.91
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ALNY is experiencing selling pressure, which indicates risk of future bearish movement.

KRYS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.66 Buy
Relative Strength Index (14 RSI): 46.47 Sell
Chaikin Money Flow: -204073 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (172.45 - 185.93) Sell
Bollinger Bands (100): (176.63 - 199.01) Sell

ALNY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.34 Sell
Relative Strength Index (14 RSI): 36.47 Sell
Chaikin Money Flow: -380729 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (269.32 - 291.86) Sell
Bollinger Bands (100): (249.36 - 281.56) Sell

KRYS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 185.86 Sell
20-day SMA: 179.59 Sell
50-day SMA: 181.29 Sell
200-day SMA: 173.05 Buy
8-day EMA: 183.91 Sell
20-day EMA: 181.59 Sell
50-day EMA: 181.97 Sell
200-day EMA: 170.16 Buy

ALNY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 269.89 Sell
20-day SMA: 279.03 Sell
50-day SMA: 274.26 Sell
200-day SMA: 209.58 Buy
8-day EMA: 269.04 Sell
20-day EMA: 274.23 Sell
50-day EMA: 271.95 Sell
200-day EMA: 230.44 Buy

Krystal Biotech Earnings Growth & KRYS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $5.65 per share, and an increase next year of $1.53 per share.

Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.86 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.46 per share, and an increase next year of $0.61 per share.

Krystal Biotech Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Alnylam Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):